89 related articles for article (PubMed ID: 22464675)
1. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease.
Janssen CE; Rose CD; De Hertogh G; Martin TM; Bader Meunier B; Cimaz R; Harjacek M; Quartier P; Ten Cate R; Thomee C; Desmet VJ; Fischer A; Roskams T; Wouters CH
J Allergy Clin Immunol; 2012 Apr; 129(4):1076-84. PubMed ID: 22464675
[TBL] [Abstract][Full Text] [Related]
2. Blau Syndrome With Delayed Cutaneous Manifestations: A Case Report.
Panah E; Garfield E; Zahirsha Z; Muhlbauer A; Lake E; Speiser J
Am J Dermatopathol; 2024 Jun; 46(6):381-382. PubMed ID: 38648024
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome.
Jensen ME; Harrell K; McBride JD
Front Immunol; 2023; 14():1279329. PubMed ID: 37868966
[TBL] [Abstract][Full Text] [Related]
4. Role of Nod2 in the development of Crohn's disease.
Yamamoto S; Ma X
Microbes Infect; 2009 Oct; 11(12):912-8. PubMed ID: 19573617
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of cytokines and apoptosis in tuberculous lymphadenitis.
Mustafa T; Mogga SJ; Mfinanga SG; Mørkve O; Sviland L
Immunology; 2006 Apr; 117(4):454-62. PubMed ID: 16556259
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary granulomas confirmed in Blau syndrome using TBLC specimens: Case report.
Shimizu Y; Kushima Y; Tanaka A; Takemasa A; Ishida K; Niho S
Front Med (Lausanne); 2024; 11():1380236. PubMed ID: 38933100
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: a pilot study.
Furusato E; Shen D; Cao X; Furusato B; Nussenblatt RB; Rushing EJ; Chan CC
Histol Histopathol; 2011 Sep; 26(9):1145-51. PubMed ID: 21751146
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Proinflammatory Cytokine Expression and Clinical Data in Apical Granuloma.
Rodrigues RCV; Porpino MTM; Dessaune-Neto N; Antunes HS; Pinto KMMC; Provenzano JC; Pires FR; Siqueira JF; Armada L
J Endod; 2024 Apr; 50(4):499-505. PubMed ID: 38311115
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical observation of lysozyme in macrophages and giant cells in human granulomas.
Yamashita K; Iwamoto T; Iijima S
Acta Pathol Jpn; 1978 Sep; 28(5):689-95. PubMed ID: 367052
[TBL] [Abstract][Full Text] [Related]
10. Granulomas in Pediatric Liver Biopsies: Single Center Experience.
Shaheen M; Lei GS; Relich RF; Jarasvaraparn C; Tolliver KM; Molleston JP; González IA
Pediatr Dev Pathol; 2024; 27(3):218-227. PubMed ID: 38221675
[TBL] [Abstract][Full Text] [Related]
11. Expression of Vascular and Tissue Repair Factors in Laryngeal Granulomas.
Tateda Y; Ikeda R; Kakuta R; Izuhara K; Ogawa T; Ise K; Shimada H; Murakami K; Murakami K; Nakamura Y; Katori Y; Ohta N
Tohoku J Exp Med; 2024 Jun; ():. PubMed ID: 38925946
[No Abstract] [Full Text] [Related]
12. Immunohistochemical findings of the granulomatous reaction associated with tuberculosis.
Karimi S; Shamaei M; Pourabdollah M; Sadr M; Karbasi M; Kiani A; Bahadori M
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S234-S235. PubMed ID: 28043576
[TBL] [Abstract][Full Text] [Related]
13. Amyopathic dermatomyositis may be on the spectrum of autoinflammatory disease: A clinical review.
Sharmeen S; Christopher-Stine L; Salvemini JN; Gorevic P; Clark R; Yao Q
Rheumatol Immunol Res; 2024 Mar; 5(1):42-48. PubMed ID: 38571935
[TBL] [Abstract][Full Text] [Related]
14. Frequent Occurrence of Perianal Disease and Granuloma Formation in Patients with Crohn's Disease and Coexistent Orofacial Granulomatosis.
Malmquist M; Rabe H; Malmborg P; Gale G; Ideström M; Sigurdsson GV; Hasséus B; Wold AE; Saalman R
Dig Dis Sci; 2023 Jul; 68(7):3129-3138. PubMed ID: 36646935
[TBL] [Abstract][Full Text] [Related]
15. Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome.
Chang SY; Kambe N; Fan WL; Huang JL; Lee WI; Wu CY
Pediatr Rheumatol Online J; 2022 Oct; 20(1):86. PubMed ID: 36192768
[TBL] [Abstract][Full Text] [Related]
16. Potential Composite Digenic Contribution of
Azab B; Rabab'h O; Aburizeg D; Mohammad H; Dardas Z; Mustafa L; Khasawneh RA; Awad H; Hatmal MM; Altamimi E
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741735
[TBL] [Abstract][Full Text] [Related]
17. Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis.
Matsuda T; Kambe N; Takimoto-Ito R; Ueki Y; Nakamizo S; Saito MK; Takei S; Kanazawa N
Front Immunol; 2022; 13():895765. PubMed ID: 35711422
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases.
Tanaka T; Shiba T; Honda Y; Izawa K; Yasumi T; Saito MK; Nishikomori R
Front Immunol; 2022; 13():870535. PubMed ID: 35603217
[TBL] [Abstract][Full Text] [Related]
19. Multinucleated Giant Cells: Current Insights in Phenotype, Biological Activities, and Mechanism of Formation.
Ahmadzadeh K; Vanoppen M; Rose CD; Matthys P; Wouters CH
Front Cell Dev Biol; 2022; 10():873226. PubMed ID: 35478968
[TBL] [Abstract][Full Text] [Related]
20. Targeting interferon-γ in hyperinflammation: opportunities and challenges.
De Benedetti F; Prencipe G; Bracaglia C; Marasco E; Grom AA
Nat Rev Rheumatol; 2021 Nov; 17(11):678-691. PubMed ID: 34611329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
